The declaration from New Jersey Commissioner of Environmental Protection Shawn LaTourette is the first of its kind since 2016. It comes amid persistent hot, dry conditions that are stressing supplies and urges residents and businesses to conserve water.

The legislation would incentivize businesses from across the Hudson River for setting up locations here for their Garden State workers.

Jeff Carter joins the Florham Park-based direct mortgage lender as chief operating officer. Peter Alvarez, who currently holds that title, has been named chief lending officer.

Gov. Phil Murphy recently requested the state comptroller look into New Jersey City University's financial situation. According to a spokesperson for the school, the move is well-received as it works "collaboratively with our partners ... to move our institution onto solid ground and set it on a path to future sustainability."

The multiyear effort will work to spread awareness about non-opioid options to manage acute and chronic pain, including by educating retired players, NFLA chapter presidents and staff, and youth sports organizations.

The annual recognition highlights top hospitals for labor and delivery and gynecologic procedures across a trio of award categories. Nationwide, just 17 facilities earned all three, including one from the Garden State.

Based in the firm's Morristown office, a trio of new additions from food tech startup Wonder will lead efforts in the Northeast and nationwide.

Robert Pohlman joined the Wall-based company in 2011. As vice president for Clean Energy Ventures, he'll oversee what President and CEO Steve Westhoven referred to as a "core part of our business and growth strategy."

Camie Shelmire brings 20 years of leadership experience in talent, client strategy and operations to the tech company, which over the past two years has doubled its workforce to more than 5,300 worldwide.

Dr. Mathai Mammen serves as executive vice president of pharmaceuticals, R&D.

Harry Madonna's return to the chief executive role at the financial institution coincides with the resignation of Vernon Hill as chair of its board, seemingly marking the end of a tumultuous proxy war and the start of a new chapter for the company.

Flow cytometry is an emerging technology that can help medical professionals better understand disease, according to Dr. Bill Hanlon, chief scientific officer at the North Carolina-based life sciences company.